CD44 and breast carcinoma: In this study we employed the luminal ER+ MCF-7 and the IBC SUM149PT breast cancer cells to establish the extent to which high grade of CIN and chemoresistance was mechanistically linked to the enrichment of CD44+/CD24low/− CSCs.